Trade OBIO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Orchestra BioMed Holdings, Inc. (OBIO) is trading at US$5.13, up 0.31% today as of Aug 28, 11:15 EDT. The company has a market capitalisation of US$322.16M. Over the past 52 weeks, OBIO has traded between US$2.20 and US$5.78. On Syfe you can trade OBIO with $0 commission and add it to your watchlist.
| Previous close | US$5.11 |
|---|---|
| Market cap | US$322.16M |
| 52-week range | US$2.20 – US$5.78 |
| Volume | 220.53K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Orchestra BioMed Holdings, Inc.
Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded by David P. Hochman on May 25, 2020 and is headquartered in New Hope, PA.
Year: 2023
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $10 From $12, Keeps Buy Rating
May 19, 11:42 AM · MT Newswires
Orchestra BioMed Q1 Loss Narrows, Revenue Falls
May 12, 8:55 PM · MT Newswires
Orchestra BioMed Gets Second FDA Breakthrough Designation for Hypertension Therapy
Apr 30, 2:29 PM · MT Newswires
Orchestra BioMed Holdings, Inc. (OBIO) stock is trading at US$5.13, +0.31% from the previous close of US$5.11.
The market cap for Orchestra BioMed Holdings, Inc. (OBIO) stock is approximately US$322.16M.
The 52-week high for Orchestra BioMed Holdings, Inc. (OBIO) stock is US$5.78.
The 52-week low for Orchestra BioMed Holdings, Inc. (OBIO) stock is US$2.20.
Orchestra BioMed Holdings, Inc. (OBIO) does not currently pay a dividend.
Stay on top of OBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
